Point-of-care leadership Cholestech focuses on rapid, affordable diagnostic testing at the point of care for cholesterol, lipids, glucose, inflammation and liver enzymes, suggesting opportunities to upsell broader POC lab integration, handheld analyzers, and consumables for clinics and SMB healthcare facilities.

Mid-market scale With 51-200 employees and annual revenue in the 10M–25M range, Cholestech sits in a mid-market niche ideal for channel partnerships, OEM collaborations, and bundled offerings with larger distributors serving urgent care centers, clinics, and independent labs.

Expansion potential The emphasis on rapid testing solutions positions Cholestech to expand into telehealth-enabled remote monitoring kits and periodic screening programs, targeting health plans and employer wellness programs seeking cost-effective, fast diagnostics.

Competitive positioning Operating alongside larger diagnostics players, Cholestech differentiates with speed, affordability, and point-of-care convenience; sales strategies can emphasize integrated workflows, training packages for staff, and value-based pricing for small to mid-size facilities.

Growth-focused alliances Given similarities to mid-sized diagnostics peers, opportunities exist in partnerships with distributors and schools, clinics, and employer health programs, plus potential OEM collaborations to embed Cholestech assays into broader diagnostic ecosystems.